Ankylosing spondylitis treatment in China integrates Western biologics, biosimilars, and targeted therapies with traditional recovery protocols. Patients access advanced IL-17A inhibitors like secukinumab and TNF-alpha inhibitors in JCI-accredited centers. Specialized programs often combine these medications with manual therapy and systemic rehabilitation for spinal mobility.
- Biologic therapy: Domestic etanercept biosimilars and original brands target spinal inflammatory markers.
- Manual therapy: Chief therapists like Dr. Li Guo Qiang lead intensive physical programs.
- Inpatient rehabilitation: Protocols often include 21-day hospital stays for comprehensive physical therapy.
- Surgical intervention: Orthopedic experts perform spinal deformity corrections and joint replacements in Beijing.
Bookimed Expert Insight: Yanda International Hospital stands out by offering intensive 21-day inpatient physiotherapy packages. While many global clinics focus on outpatient drug management, this long-term approach accommodates international patients needing supervised recovery. The facility maintains JCI accreditation and manages a massive volume of 2,500,000 patients annually across 39 departments.
Patient Consensus: Patients find that combining Western biologics with traditional methods like acupuncture helps manage morning stiffness effectively. Accessing these advanced treatments usually requires traveling to major urban centers like Beijing or Shanghai.